Myeloproliferative Neoplasms (MPNs) Flashcards
MPNs
monoclonal hyperprolifferation abnormalities (neoplasms) or myeloproliferative neoplasms.
What are the four types of MPNs?
- PV
- CML
- ET
- PMF (primary myelofibrosis)
Polycythemia Vera
unregulated proliferation of BM erythroid, granulocytic & megakaryocytes
PV Etiology
- gene mutation JAK2
-even though hyperactivity of JAK2 may not initiate PV, it is associated
JAK2 gene
nonreceptor tyrosine kinase that plays a role in EPO and TPO receptors
PV diagnosis
-2 major and 1 minor criteria must be met.
2 major criteria
- Hgb 18.5 M; 16.5F
- ID of JAK2 mutation
1 minor criteria
- panmyelosis in BM
- low EPO
- autonomous, erythroid
PV clinical symptoms
- Ruddy face
- itchy skin
- HTN
- vertigo
- feeling full
-blurred VA
-↑uric acid
-splenomegaly
-↑B12 serum - ↓Fe storage or absent
Lab findings
- RBCt=6-10x10^6/uL- severe crowding
-difficult pB smear - Hgb>18
- Hct=55-60%
-ESR =0-3mm/hr
-n or ↑WBC & plts w/ n. morph
-immature granulocytes - plts=400,000 to 2 mil
-BM hypercellular w/worsening fibrosis - ↓FE stable to spent phase
-nRBC
PV Tx’t
no cure, therapeutic phlebotomy 1st choice, myelosupressive drugs: ↓BV & ↑Fe stores.
Explain the etiology of Chromic Myelocytic Leukemia
an extreme elevation of mature/immature myeloid cells in BM which then show up in the p.B.
-This arises from a single translocation putting c-ABL next to BCR yielding BCR/ABL.
-BCR/ABL=↑ tyrosine kinase activity leading to hyperproliferation + unstable.
What are the lab findings in CML
- “when pB looks like B.M.”
- remember extreme elevation so >100,000/uL & usually 200,000-500,000/uL w/ neutrophilia, basophilia, & eosinophilia
- p.B has huge shift to the left w/ all developmental stages
- > 20% basophilia comes before blast crisis
- Abnormal cytogenetics
- M:E ratio 10:1-50:1 but when blasts are <30%
- ↑ plts or ↓ (>700,000 or <150,000/uL
What are the diagnostic testing for CML?
- karyotyping (chromosomal)
-FISH (cellular level) - PCR (molecular level)
-LAP decreased in early stages - BM shows striking increase in M:E ratio ranging from 10:1 to 50:1
Differentiate between the three phases of CML
- Chronic
- Accelerated: poor response to therapies and increased symptoms
- Blastic: 3/4 of pts undergo “blast transformation”. Blast >20% which can then indicate turning into either AML or ALL (rare).
*blastic phase involves pB, BM, & extramedullary tissues